T医药集团资金集中管理优化研究-工商管理专业论文.docxVIP

万方数据 万方数据 Abstract With the development of economic globalization, the scale of the enterprise group is more and more big, regional distribution is more and more widely. Enterprise group funds scattered and lack of control of the growing problem of. Money, blood is often compared to the enterprise group, is the core part of the enterprise group financial management. For large enterprise groups, how to make full use of its advantages in capital scale and improving resource synergy effect, has become an important factor to measure modern enterprise comprehensive strength. Money management tends to highly concentrated is the inevitable choice of enterprise management, implementation of centralized management of funds, has become a modern enterprise group is the most important management means. Through the centralized management of funds, not only can make money more adequate use of resources, standardize enterprise budget, funds transfer, internal debt, such as product sales, purchases, cash settlement behavior, but also can to sharply cut use of financing and financing cost, realize the unity of the security, liquidity and profitability of capital operation. T pharmaceutical group, as a state-owned enterprise, the more the need for cash management optimization, while increasing the efficiency of management of funds, to strengthen the control of the money. Research methods of this article is mainly combining normative research and case study, using the related theory foundation, the internal capital market theory, transaction cost theory, and with financial theory, in T medicine group on the basis of the practice of centralized fund management, combining with the advanced theory of domestic and foreign funds centralized management knowledge, analyzing the status quo of the T medical group fund management and the existing problems in fund management, optimization, and for future group in the centralized fund management improvement is put forward a series of coping strat